Company Announcements

Purchase of Shares by Employee Benefit Trust

Source: RNS
RNS Number : 7112V
Elixirr International PLC
09 July 2024
 

ELIXIRR INTERNATIONAL PLC

("Elixirr", the "Company" or the "Group")

 

Purchase of Shares by Employee Benefit Trust

 

and

Director/PDMR Shareholding

Elixirr International plc (AIM:ELIX), an established, global award-winning challenger consultancy, announces that the Elixirr International plc Employee Benefit Trust (the "EBT") purchased from certain Directors, PDMRs, employees and shareholders of the Company (the "Purchase") 1,419,890 ordinary shares in the capital of the Company ("Ordinary Shares") at a price of 565 pence per Ordinary Share.

The Purchase has been made at the instruction of Apex Group Fiduciary Services Limited as independent trustee of the EBT following a recommendation by the Board of the Company. The decision to make the Purchase is to ensure that the EBT has sufficient shares to satisfy demand including for satisfaction of options, equity for new Partners and equity for those joining the firm through acquisition. Accordingly, the Purchase will mitigate the need for dilution in the equity of the Company as it executes on its growth strategy.

Following the Purchase, the EBT's beneficial holding is 1,782,344 Ordinary Shares representing 3.8 per cent of the issued share capital of the Company.

Participation by certain Directors and PDMRs in the Purchase are outlined in the table below:

Director/PDMR

Position

Ordinary Shares Sold

Share Sale Price

Resultant Holding

% of total voting rights

Gavin Patterson

Chair

176,991

565p

439,679

0.9%

Simon Retter

Non-Executive Director

88,496

565p

288,237

0.6%

Ian Ferguson

Executive Director

176,991

565p

2,417,091

5.1%

Nicholas Willott

Finance Director & Company Secretary

20,000

565p

254,073

0.5%

Clare Filby

Chief Operating Officer

35,398

565p

498,400

1.1%

Eric Rich

Partner

79,651

565p

592,118

1.3%

Brandon Bichler

Partner

69,479

565p

642,712

1.4%

Dieter Halfar

Partner

44,248

565p

316,461

0.7%

Daniel Garsin

Partner

24,651

565p

221,855

0.5%

 

 

For further information please contact:

Elixirr International plc

Stephen Newton, CEO

Graham Busby, CFO

 

 

 

 

Public and Investor Relations contacts:

investor-relations@elixirr.com 

 

Cavendish Capital Markets Ltd (Nominated Adviser & Joint Broker)

Stephen Keys, Charlie Beeson (Corporate Finance)

Sunila de Silva (Corporate Broking)

 

Investec Bank plc (Joint Broker)

Carlton Nelson, Henry Reast (Corporate Broking)

 

 

 

 

 

+44 (0) 20 7220 0500

 

 

    +44 (0) 20 7597 4000

 

 



About Elixirr International plc

Elixirr is an established global award-winning management consultancy, challenging the larger consultancies by delivering innovative and bespoke solutions to a repeat, globally-recognised client base.

Elixirr was founded in 2009, by Stephen Newton, Graham Busby, Ian Ferguson, Andy Curtis and Mark Goodyear, experienced business advisors who identified a market opportunity to provide bespoke, personal services as a 'challenger' to the traditional consultancy businesses in the market. Elixirr guides its clients to overcome challenges such as: future-proofing against technological disruption; development and roll-out of new propositions, products and services; incubating new businesses; navigating a more complex and multinational regulatory environment; and project management and implementation of major change programmes.

 

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them

 

1. 

Details of the person discharging managerial responsibilities / person closely associated

a)

Name

1.   Gavin Patterson

2.   Simon Retter

3.   Ian Ferguson

4.   Nicholas Willott

5.   Clare Filby

6.   Eric Rich

7.   Brandon Bichler

8.   Dieter Halfar

9.   Daniel Garsin

 

2. 

Reason for the Notification

a)

Position/status

1.   Director

2.   Director

3.   Director

4.   PDMR

5.   PDMR

6.   PDMR

7.   PDMR

8.   PDMR

9.   PDMR

b)

Initial notification/Amendment

Initial Notification

3. 

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Elixirr International plc

b)

LEI

213800MKY7OHMVAKW681

4. 

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the Financial instrument, type of instrument

Ordinary shares of 0.005p each ("Ordinary Shares")

Identification code

GB00BLPHTX84

b)

Nature of the transaction

Sale of Ordinary Shares

c)

Price(s) and volume(s)

Director/PDMR

Price(s)

Volume(s)

Gavin Patterson

565p

176,991

Simon Retter

565p

88,496

Ian Ferguson

565p

176,991

Nicholas Willott

565p

20,000

Clare Filby

565p

35,398

Eric Rich

565p

79,651

Brandon Bichler

565p

69,479

Dieter Halfar

565p

44,248

Daniel Garsin

565p

24,651

 

d)

Aggregated information:

· Aggregated volume

· Price

 

As in 4c) above

e)

Date of the transaction

8 July 2024

f)

Place of the transaction

Off market transaction

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHUKSRRSOUBRAR